Silver Book Fact

Fact image

Five-year Relative Survival (%) during Three Time Periods by Cancer Site

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The 5-year survival rate for prostate cancer has increased from 67% to nearly 100% over the past 20 years.  
  • The use of imatinib (Gleevec) has increased the eight-year survival rate for early chronic-phase myelogenous leukemia from 65% to 84%.  
  • A 10 percent reduction in cancer-related deaths in the U.S. would be worth an estimated $4.4 trillion to current and future generations.  
  • According to the Pharmaceutical Research and Manufacturers of America, a medicine in development targets CA125, a surface protein, or antigen, that is released in excess quantities by some ovarian cancers.…  
  • Gains in healthy years of life and social value from cancer R&D